Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cortot

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
Gastroenterologie Clinique Et Biologique|April 1, 1988
Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancerJ F Colombel, M Parent, D Lescut, et al.
Revue Des Maladies Respiratoires|May 9, 2026
[Resistance to immunotherapy in non-small cell lung cancer: State of the art]J Ancel, M Dewolf, B Nawrocki-Raby, et al.
The New England Journal of Medicine|August 6, 1998
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study GroupO O Thomsen, A Cortot, D Jewell, et al.
Gastroenterologie Clinique Et Biologique|September 14, 2010
A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacksA Baudet, J-F Colombel, A Cortot, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2010
Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's diseaseP Zerbib, D Koriche, S Truant, et al.
La Revue De Medecine Interne|March 6, 2002
[Unusual association: hepatic peliosis and Crohn's disease]D Launay, P Y Hatron, V Queyrel, et al.
Gut|January 13, 2001
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's diseaseA Cortot, J F Colombel, P Rutgeerts, et al.
Gut|April 16, 1998
Anticipation in familial Crohn's diseaseB Grandbastien, M Peeters, D Franchimont, et al.
The American Journal of Gastroenterology|May 1, 1994
Comparison of omeprazole and famotidine on esophageal pH in patients with moderate to severe esophagitis: a cross-over studyP Ducrotté, F Guillemot, L Elouaer-Blanc, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1995
Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitisM Lémann, A Galian, P Rutgeerts, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
Gastroenterologie Clinique Et Biologique|April 1, 1988
Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancerJ F Colombel, M Parent, D Lescut, et al.
Revue Des Maladies Respiratoires|May 9, 2026
[Resistance to immunotherapy in non-small cell lung cancer: State of the art]J Ancel, M Dewolf, B Nawrocki-Raby, et al.
The New England Journal of Medicine|August 6, 1998
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study GroupO O Thomsen, A Cortot, D Jewell, et al.
Gastroenterologie Clinique Et Biologique|September 14, 2010
A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacksA Baudet, J-F Colombel, A Cortot, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2010
Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's diseaseP Zerbib, D Koriche, S Truant, et al.
La Revue De Medecine Interne|March 6, 2002
[Unusual association: hepatic peliosis and Crohn's disease]D Launay, P Y Hatron, V Queyrel, et al.
Gut|January 13, 2001
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's diseaseA Cortot, J F Colombel, P Rutgeerts, et al.
Gut|April 16, 1998
Anticipation in familial Crohn's diseaseB Grandbastien, M Peeters, D Franchimont, et al.
The American Journal of Gastroenterology|May 1, 1994
Comparison of omeprazole and famotidine on esophageal pH in patients with moderate to severe esophagitis: a cross-over studyP Ducrotté, F Guillemot, L Elouaer-Blanc, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1995
Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitisM Lémann, A Galian, P Rutgeerts, et al.
Pageof 23